title: Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus: A National Health System Perspective In Spain.
authors.affiliation: Pfizer S. L. U., Alcobendas/Madrid, Spain.
authors.forename: Gutiérrez J
authors.initials: GJ
authors.lastname: Rejas
authors.affiliation: Badalona Serveis Assistencials SA, Badalona (Barcelona), Spain.
authors.forename: Mainar A
authors.initials: MA
authors.lastname: Sicras
authors.affiliation: Hospital Germans Trias i Pujol, Badalona (Barcelona), Spain.
authors.forename: Artieda R
authors.initials: AR
authors.lastname: Navarro
authors.affiliation: Pfizer, S. L. U, Alcobendas/Madrid, Spain.
authors.forename: Lossada Juste A
authors.initials: LJ
authors.lastname: De